Summary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Monthly Archives
January 2022
-
-
AgrochemicalsGlobal Market
Catalent Completes $10M Expansion at US and UK Production Sites
by adminby adminSummary : CDMO giant Catalent completed expansion projects worth $10 million that added large-scale isolator units to its Malvern, Pennsylvania, and Dartford,…
-
Summary : On his company’s recent spending spree to build manufacturing capacity, Fujifilm Diosynth CEO Martin Meeson said three months ago: “We’re…
-
Summary : Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines. As interest…
-
AgrochemicalsGlobal Market
Enrol call: Verona recruits 800 patients for COPD trial
by adminby adminSummary : The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed…
-
AgrochemicalsCovid DrugsIndia
Researchers from CDRI working to develop two new Covid-19 drugs
by adminby adminSummary : A team of scientists led by chief scientist Ravishankar is working on two combinations to provide the safest medication to coronavirus patients.…
-
AgrochemicalsGlobal Market
Singapore approves Covid-19 vaccine boosters for age 12-17s
by adminby adminSummary : Singapore will extend its COVID-19 booster vaccination programme to adolescents aged 12 to 17 years from next month, its health…
-
Chennai: The city-based laboratory says it has developed an RT-PCR test kit that can detect the Covid-19 virus in 45 minutes and…
-
CompaniesGlobal MarketPfizerPharma Science & Research
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…
-
Biocon PharmaceuticalCompaniesGlobal Market
Biocon Biologics set to reap Biosimilar Insulin Glargine Opportunity in US
by adminby adminSummary : Drugmaker is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit…